Diabetes and chronic kidney disease: Lessons from the Pima Indians

Pediatric Nephrology

Volumn 23, Issue 11, 2008, Pages 1933-1940

  Lemley, Kevin V ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Albuminuria; Glomerulus; Nephropathy; Podocyte; Progression

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOXIA INDUCIBLE FACTOR 1; PLACEBO; PYRIDOXAMINE; VASCULOTROPIN A; VON HIPPEL LINDAU PROTEIN;

AMERICAN INDIAN; APOPTOSIS; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; ENVIRONMENTAL FACTOR; GENETIC POLYMORPHISM; GENETIC RISK; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY HYPERTROPHY; KIDNEY TUBULE BASEMENT MEMBRANE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; RENAL PROTECTION; REVIEW; RISK FACTOR; RISK REDUCTION; SIGNAL TRANSDUCTION;

DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; HUMANS; INDIANS, NORTH AMERICAN; RENAL INSUFFICIENCY, CHRONIC;

EID: 53749107416     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-008-0763-8     Document Type: Review

References (47)

1. Pavkov ME, Bennett PH, Knowler WC, Krakoff J, Sievers ML, Nelson RG (2006) Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians. JAMA 296:421-426
2. Pavkov ME, Knowler WC, Bennett PH, Looker HC, Krakoff J, Nelson RG (2006) Increasing incidence of proteinuria and declining incidence of end-stage renal disease in diabetic Pima Indians. Kidney Int 70:1840-1846
3. The ESRD Incidence Study Group; Stewart JH, McCredie MR, Williams SM (2006) Divergent trends in the incidence of end-stage renal disease due to Type 1 and Type 2 diabetes in Europe, Canada and Australia during 1998-2002. Diabet Med 23:1364-1369
4. Hasslacher C, Ritz E, Wahl P, Michael C (1989) Similar risks of nephropathy in patients with type I or type II diabetes mellitus. Nephrol Dial Transplant 4:859-863
5. Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, Orchard TJ (2006) The 30-year natural history of type 1 diabetes complications: The Pittsburgh epidemiology of diabetes complications study experience. Diabetes 55:1463-1469
6. Parving HH, Gall MA, Skott P, Jorgensen HE, Lokkegaard H, Jorgensen F, Nielsen B, Larsen S (1992) Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 41:758-762
7. Fioretto P, Mauer M (2007) Histopathology of diabetic nephropathy. Semin Nephrol 27:195-207
8. White KE, Bilous RW (2000) Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease. J Am Soc Nephrol 11:1667-1673
9. Myers BD, Nelson RG, Williams GW, Bennett PH, Hardy SA, Berg RL, Loon N, Knowler WC, Mitch WE (1991) Glomerular function in Pima Indians with noninsulin-dependent diabetes mellitus of recent onset. J Clin Invest 88:524-530
10. Gorman D, Sochett E, Daneman D (1999) The natural history of microalbuminuria in adolescents with type 1 diabetes. J Pediatr 134:333-337
11. Lemley KV, Blouch K, Abdullah I, Boothroyd DB, Bennett PH, Myers BD, Nelson RG (2000) Glomerular permselectivity at the onset of nephropathy in type 2 diabetes mellitus. J Am Soc Nephrol 11:2095-2105
12. Lemley KV (2003) A basis for accelerated progression of diabetic nephropathy in Pima Indians. Kidney Int 63[Suppl 83]:S38-S42
13. Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, Coplon NS, Sun L, Meyer TW (1997) Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 99:342-348
14. Schmidt K, Pesce C, Liu Q, Nelson RG, Bennett PH, Karnitschnig H, Striker LJ, Striker GE (1992) Large glomerular size in Pima Indians: lack of change with diabetic nephropathy. J Am Soc Nephrol 3:229-235
15. Perrin NE, Torbjörnsdotter TB, Jaremko GA, Berg UB (2004) Follow-up of kidney biopsies in normoalbuminuric patients with type 1 diabetes. Pediatr Nephrol 19:1004-1013
16. Lemley KV, Abdullah I, Myers BD, Meyer TW, Blouch K, Smith WE, Bennett PH, Nelson RG (2000) Evolution of incipient nephropathy in type 2 diabetes mellitus. Kidney Int 58:1228-1237
17. Meyer TW, Bennett PH, Nelson RG (1999) Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria. Diabetologia 42:1341-1344
18. Toyoda M, Najafian B, Kim Y, Caramori ML, Mauer M (2007) Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Diabetes 56:2155-2160
19. Nelson RG, Bennett PH, Beck GJ, Tan M, Knowler WC, Mitch WE, Hirschman GH, Myers BD (1996) Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. N Engl J Med 335:1636-1642
20. Najafian B, Kim Y, Crosson JT, Mauer M (2003) Atubular glomeruli and glomerulotubular junction abnormalities in diabetic nephropathy. J Am Soc Nephrol 14:908-917
21. Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC (1984) Structural-functional relationships in diabetic nephropathy. J Clin Invest 74:1143-1155
22. Nosadini R, Velussi M, Brocco E, Bruseghin M, Abaterusso C, Saller A, Dalla VM, Carraro A, Bortoloso E, Sambataro M, Barzon I, Frigato F, Muollo B, Chiesura-Corona M, Pacini G, Baggio B, Piarulli F, Sfriso A, Fioretto P (2000) Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes 49:476-484
23. Christensen PK, Larsen S, Horn T, Olsen S, Parving HH (2001) Renal function and structure in albuminuric type 2 diabetic patients without retinopathy. Nephrol Dial Transplant 16:2337-2347
24. Kretzler M (2005) Role of podocytes in focal sclerosis: Defining the point of no return. J Am Soc Nephrol 16:2830-2832
25. Mogensen CE, Christensen CK (1984) Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89-93
26. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1:1430-1432
27. Remuzzi G, Ruggenenti P, Benigni A (1997) Understanding the nature of renal disease progression. Kidney Int 51:2-15
28. Russo LM, Sandoval RM, Brown D, Molitoris BA, Comper WD (2007) Controversies in nephrology: Response to 'renal albumin handling, facts, and artifacts'. Kidney Int 72:1195-1197
29. Deen WM, Bridges CR, Brenner BM, Myers BD (1985) Heteroporous model of glomerular size selectivity: Application to normal and nephrotic humans. Am J Physiol 249:F374-F389
30. White KE, Bilous RW (2004) Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients. Nephrol Dial Transplant 19:1437-1440
31. Berg UB, Torbjörnsdotter TB, Jaremko G, Thalme B (1998) Kidney morphological changes in relation to long-term renal function and metabolic control in adolescents with IDDM. Diabetologia 41:1047-1056
32. Torbjörnsdotter TB, Perrin NE, Jaremko GA, Berg UB (2005) Widening of foot processes in normoalbuminuric adolescents with type 1 diabetes. Pediatr Nephrol 20:750-758
33. Kriz W, Elger M, Mundel P, Lemley KV (1995) Structure-stabilizing forces in the glomerular tuft. J Am Soc Nephrol 5:1731-1739
34. Lemley KV, Lafayette RA, Safai M, Derby G, Blouch K, Squarer A, Myers BD (2002) Podocytopenia and disease severity in IgA nephropathy. Kidney Int 61:1475-1485
35. Kumar D, Robertson S, Burns K (2004) Evidence of apoptosis in human diabetic kidney. Mol Cell Biochem 259:67-70
36. Verzola D, Gandolfo MT, Ferrario F, Rastaldi MP, Villaggio B, Gianiorio F, Giannoni M, Rimoldi L, Lauria F, Miji M, Deferrari G, Garibotto G (2007) Apoptosis in the kidneys of patients with type II diabetic nephropathy. Kidney Int 72:1262-1272
37. Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Ebihara I, Koide H (2000) Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant 15:1379-1383
38. Nakamura T, Ushiyama C, Osada S, Hara M, Shimada N, Koide H (2001) Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria. Metabolism 50:1193-1196
39. Imperatore G, Knowler WC, Pettitt DJ, Kobes S, Bennett PH, Hanson RL (2000) Segregation analysis of diabetic nephropathy in Pima Indians. Diabetes 49:1049-1056
40. Foy CA, McCormack LJ, Knowler WC, Barrett JH, Catto A, Grant PJ (1996) The angiotensin-I converting enzyme (ACE) gene I/D polymorphism and ACE levels in Pima Indians. J Med Genet 33:336-337
41. Red Eagle A, Hanson R, Jiang W, Han X, Matters G, Imperatore G, Knowler W, Bond J (2005) Meprin β metalloprotease gene polymorphisms associated with diabetic nephropathy in the Pima Indians. Hum Genet 118:12-22
42. Brukamp K, Jim B, Moeller MJ, Haase VH (2007) Hypoxia and podocyte-specific Vhlh deletion confer risk of glomerular disease. Am J Physiol 293:F1397-F1407
43. Nelson RG, Morgenstern H, Bennett PH (1998) Birth weight and renal disease in Pima Indians with type 2 diabetes mellitus. Am J Epidemiol 148:650-656
44. Osterby R, Hartmann A, Nyengaard J, Bangstad HJ (2002) Development of renal structural lesions in type-1 diabetic patients with microalbuminuria. Virchows Arch 440:94-101
45. Kriz W (2004) Podocytes as a target for treatment with ACE inhibitors and/or angiotensin-receptor blockers. Kidney Int 65:333-334
46. Huber TB, Gloy J, Henger A, Schollmeyer P, Greger R, Mundel P, Pavenstadt H (1998) Catecholamines modulate podocyte function. J Am Soc Nephrol 9:335-345
47. Hara M, Yanagihara T, Kihara I (2007) Cumulative excretion of urinary podocytes reflects disease progression in IgA nephropathy and Schonlein-Henoch purpura nephritis. Clin J Am Soc Nephrol 2:231-238